Lv1
48 积分 2025-08-15 加入
Antibody-drug conjugate design and mechanisms of action for cancer treatment: state of the art and beyond
5天前
已完结
The antibody–drug conjugate landscape
5天前
已完结
Antibody-Drug Conjugate Overview: a State-of-the-art Manufacturing Process and Control Strategy
5天前
已完结
Generation and Characterization of Iduronidase-Cleavable ADCs
1个月前
已完结
Comparative Study on Covalent and Noncovalent Endogenous Albumin-Binding β-Glucuronidase-Activated SN38 Prodrugs for Antitumor Efficacy
1个月前
已完结
Linker Chemistry in Antibody–Drug Conjugates: Current Strategies, Clinical Pharmacokinetic Analyses, and Linker-Free Outlooks
1个月前
已完结
Effect of Linker Stereochemistry on the Activity of Indolinobenzodiazepine Containing Antibody–Drug Conjugates (ADCs)
1个月前
已完结
Optimizing lysosomal activation of antibody-drug conjugates (ADCs) by incorporation of novel cleavable dipeptide linkers
1个月前
已完结
Antibody–drug conjugates come of age in oncology
4个月前
已完结
Determination of protease cleavage site motifs using mixture-based oriented peptide libraries
4个月前
已完结
皖公网安备34019202002308
